Short-term Preoperative Treatment With Enzalutamide, Alone or in Combination With Exemestane in Primary Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Primary Breast Cancer ER+ve|Primary Breast Cancer AR+ve TNBN
Interventions: DRUG: Enzalutamide|DRUG: Exemestane
Sponsor: Queen Mary University of London
Collaborators: Astellas Pharma Inc